1. 17:00 – 19:00 | Sunday, 30 June, 2013 Session Room 3 Kuala Lumpur Convention Centre (KLCC) Kuala Lumpur, Malaysia Chair: Nicholas Paton

2. OPENING REMARKS Dr. Nicholas Paton Singapore

3. 2 Agenda 17:00–17:05Opening Remarks Nicholas Paton, Singapore 17:05–17:35Cryptococcal meningitis and tuberculosis Andrew Kambugu, Uganda 17:35–18:05HIV-associated neurocognitive disorder (HAND) Patrick Li, Hong Kong 18:05–18:35Hepatitis B and C Jürgen Rockstroh, Germany 18:35–18:50Discussion / Q&APanel 18:50–19:00Closing Remarks Nicholas Paton, Singapore

4. 3 Disclosures Speakers have acted as advisor, received speaker fees/meeting expenses, or received research grants/drug support from: Dr. Nicholas Paton: Abbott, AbbVie, Genentech, Gilead, GSK, Janssen diagnostics, Merck, Pfizer Dr. Andrew Kambugu: AbbVie, MSD Dr. Patrick Li: AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceutica, Merck Sharp & Dohme, ViiV Healthcare Dr. Jürgen Rockstroh: Abbott, AbbVie, BI, Bionor, BMS, Janssen, Merck, Novartis, Pfizer, Roche, Tibotec, Vertex, ViiV

5. 4 Housekeeping Please switch mobile phones and pagers to vibrate Kindly do not use flash photography To ask a question at the end of the symposium: – Please fill in question card and hand to a member of staff Please complete the evaluation form at the end of the symposium and hand it to a member of staff as you leave